Narrow Results

Biota Discovers New Potent Antivirals.

Celladon Partners with V-Kardia on Development of Percutaneous Delivery of Gene Therapy for Heart Failure.

Regenera Closes Multimillion Dollar Drug Deal.

Napo Pharma Collaborates with AsiaPharm.

Matrix Buys Over Belgian Company Docpharma.

Ranbaxy Buys Portfolio from Spain's EFARMES.

Japan's MediBIC and ReaMetrix India Team up.

Medical & Biological Labs and DNAVEC Establish Joint Venture Company in China.

Britsol-Meyers Squibb Collaborates with Korea's Celltrion.

YM Biosciences Partners with Kuhnil to Develop Nimotuzumab.

A Company that Helps Translate Basic Research into Useful Biomedical Products.

InfleXion Corp Develops Diagnostic Kits.

GNI and Shanghai Genomics Merge.

MerLion Announces Collaboration Agreement with Sankyo.

Schering AG Sets Up Asia-Pacific Headquarters in Singapore.

Three Global Companies Invest US$112 Million to Form Joint Venture: Interpharma, Quintiles and Temasek Holdings

CyGenics Asian Healthcare Presence Expanded in Indonesia.

Apollo's Oral Insulin Ready for Human Trials.

Australia's Mayre Faces a $2 Billiono Takeover Bid-Paper.

Starpharma to Acquire Dendritic Nanotechnologies Inc.

China Hi-TechGroup Co Ltd.

Mankind Pharma Plans to Invest US $1.5 million in Two Years.

Matrix Signs Licensing Pact with US-Based Gilead.

Ranbaxy Collaborates with Gilead Sciences for Anti-HIV Drug Tenofovir.

INDIA – A novel form of gene regulation in bacteria.

INDIA – Algal biofuels are no energy panacea.

JAPAN – Medical Data Vision enhances the quality of medical care with Actian Vectorwise.

SINGAPORE – Singapore heart surgeon to receive honour from The Royal College of Surgeons of Edinburgh.

SINGAPORE – ELGA^® to deliver innovative water purification at new Singapore General Hospital expansion.

AUSTRALIA – Specialised Therapeutics Australia: New drug to fight hospital superbug infection.

AUSTRALIA – Group of genes hold the clue in migraine cases.

AUSTRALIA – CT scans can triple risk of brain cancer, leukemia.

BRAZIL – Science can do more for sustainable development.

MIDDLE EAST – Particles and persecution: why we should care about Iranian physicists.

EUROPE – Medicyte coordinates EU-funded collaboration on Biomimetic Bioartificial Liver.

EUROPE – Selvita and Orion Pharma achieve a research milestone in Alzheimer's Disease Program.

EUROPE – Zinforo (ceftaroline fosamil) receives positive CHMP opinion in the European Union for the treatment of patients with serious skin infections or community acquired pneumonia.

USA – Vein grown from girl's own stem cells transplanted.

USA – Hidden vitamin in milk yields remarkable health benefits - Weill Cornell researchers show tiny vitamin in milk, in high doses, makes mice leaner, faster and stronger.

USA – New report finds biotechnology companies are participating in 39% of all projects in development for new medicines and technologies for neglected diseases.

USA – TriReme Medical receives FDA clearance for expanded matrix of sizes of Chocolate PTA balloon catheter.

USA – New data show investigational compound dapagliflozin demonstrated significant reductions in blood sugar levels when added to sitagliptin in adults with type 2 diabetes at 24 weeks, with results maintained over 48 weeks.

USA – Zalicus successfully completes Phase 1 single ascending dose study with Z944, a novel, oral T-Type Calcium Channel Blocker.

USA – Study provides clues to clinical trial cost savings.

Due to the increased use of composite materials in industrial applications, reliable and consistent finite element methods are required for the simulation and optimization of composite structures. In this paper, we presented the effect of finite element meshing in the modeling of degradation in composite structures under tensile stress; we have used an elastoplastic model to simulate the damage and plasticity behavior occurring in laminated composite structures carbon/epoxy: T300/914. This model works with different elements and the results obtained are not sensitive to mesh size. Thus, we have showed that two different meshes give the same results. Our findings are in good agreement compared to the experimental data.

Collagen is the most abundant natural protein found in living systems. While there is a whole family of different collagen types, each differing in sequence, the properties that make this protein so attractive as the building blocks for medical devices, are reflected largely by the unique fibrillar structure of the molecule, as well as defined functional regions that interact with the surrounding cells and other matrix components. As a commercial medical product, collagen can be part of the natural tissue used in the device, or it can be fabricated as a reconstituted product from animal or recombinant sources. Both types of uses have distinct properties that convey advantages and disadvantages to the end product. This review examines the chemistry and biology of collagen and describes some well-documented examples of collagen-based medical devices produced in one or other of these formats.